| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.00018 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 4.1e-05 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -3.3e-05 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -7.2e-07 | 1 |